BrainOmega operates a generative AI-native drug discovery platform for oncology, helping pharma, biotech and research teams test more cancer biology in less time and generate defensible predictions for drug and vaccine discovery. The platform combines cancer-tuned AI models, candidate scoring, confidence outputs and audit-ready decision traceability to accelerate early-stage therapeutic discovery.